tiprankstipranks
Zenas BioPharma, Inc. (ZBIO)
NASDAQ:ZBIO
US Market
ZBIO
Zenas BioPharma, Inc.
RESEARCH TOOLSreports
Want to see ZBIO full AI Analyst Report?

Zenas BioPharma, Inc. (ZBIO) Financial Statements

273 Followers

Zenas BioPharma, Inc. Financial Overview

Zenas BioPharma, Inc.'s market cap is currently $1.21B. The company's EPS TTM is $-4.54; its P/E ratio is -1.76; Zenas BioPharma, Inc. is scheduled to report earnings on March 16, 2026, and the estimated EPS forecast is $-1.47. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 10.00M$ 5.00M$ 50.00M$ 0.00
Gross Profit$ 9.94M$ -134.14M$ 50.00M$ -61.69M
Operating Income$ -211.38M$ -163.89M$ -37.15M$ -76.20M
EBITDA$ -211.33M$ -163.75M$ -27.03M$ -75.12M
Net Income$ -377.74M$ -156.99M$ -37.12M$ -119.28M
Balance Sheet
Cash & Short-Term Investments$ 343.19M$ 350.77M$ 56.86M$ 67.21M
Total Assets$ 383.64M$ 369.97M$ 68.18M$ 74.58M
Total Debt$ 79.96M$ 1.00M$ 21.11M$ 1.53M
Net Debt$ -30.68M$ -318.74M$ -35.74M$ -65.68M
Total Liabilities$ 141.50M$ 57.51M$ 293.90M$ 266.87M
Stockholders' Equity$ 242.14M$ 312.46M$ -225.72M$ -192.29M
Cash Flow
Free Cash Flow$ -172.35M$ -119.81M$ -30.55M$ -67.85M
Operating Cash Flow$ -172.33M$ -119.67M$ -30.53M$ -65.65M
Investing Cash Flow$ -251.89M$ -30.55M$ -17.00K$ -2.20M
Financing Cash Flow$ 215.28M$ 412.96M$ 20.12M$ 59.39M
Currency in USD

Zenas BioPharma, Inc. Earnings and Revenue History

Income Statement >

Zenas BioPharma, Inc. Debt to Assets

Balance Sheet >

Zenas BioPharma, Inc. Cash Flow

Cash Flow >

Zenas BioPharma, Inc. Forecast EPS vs Actual EPS

Earnings >